about
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivoIn vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio choleraeStudies ofToxoplasma gondiiandPlasmodium falciparumenoyl acyl carrier protein reductase and implications for the development of antiparasitic agentsType I and type II fatty acid biosynthesis in Eimeria tenella: enoyl reductase activity and structureIdentification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl ReductaseMaternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host.Understanding mechanisms and the role of differentiation in pathogenesis of Toxoplasma gondii: a reviewTargeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum.Artificial 64-Residue HIV-1 Enhancer-Binding Peptide Is a Potent Inhibitor of Viral Replication in HIV-1-Infected CellsMechanisms of Toxoplasma gondii persistence and latency.Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice.The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs.Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infectionsExpression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase.Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids.Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.Drugs in development for toxoplasmosis: advances, challenges, and current status.Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivoEnoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.Bifunctional antimicrobial conjugates and hybrid antimicrobials.Beyond Cell Penetrating Peptides: Designed Molecular Transporters.Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.Improved efficacy of fosmidomycin against Plasmodium and Mycobacterium species by combination with the cell-penetrating peptide octaarginine.Enantiomeric and diastereoisomeric (mixed) L/ D-octaarginine derivatives - a simple way of modulating the properties of cell-penetrating peptides.Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii
P2860
Q21092310-9C8735F3-7EF7-4FF7-A783-668E74EE5C01Q24647817-19F4528A-0F84-4378-8DED-950738A87789Q27643926-88351DEF-A508-4864-86EB-A94DE538E5B1Q27647201-79660CC6-2D8F-4BCB-AD63-46519BCB1F80Q27664019-B421C2EF-D6F1-4303-A435-F5ABDEC10A63Q33770602-FF033740-8995-4DBA-AC94-6DE4C4EFD71EQ33985273-9B9126A4-62B0-4EBB-8010-0EE15A02B85AQ34493284-99C2E77B-39C8-481D-A496-913D9D3E81ABQ35692292-DF1A5B91-887A-457E-BA35-458622AB0DE9Q35870650-6D26577C-7590-4DB1-BD94-655F01EEECF8Q35876115-240C8620-AB11-4B2F-B819-77DB42ABA1E1Q35941319-06D796B3-A7F0-40CB-B97C-BBECB3368CDEQ35973247-A76F1728-5CE3-478A-9165-96F59492BDD7Q36066272-9E30E365-58AD-4473-AD75-9FDCFC1A29C3Q36212957-EB733847-B339-4DDD-A8CE-D59F6625A3F9Q36459698-4C940E8C-C4E7-4441-9427-CD7A9D2642A1Q36958298-D093AE98-DA94-4C8F-93E9-0C23519FD5B1Q37128281-E50B2CDE-0C6C-45E8-BDCF-C5BFAB40A013Q37613765-C1AAF8CB-CF0F-40B9-8C21-6F44583786ECQ37635732-368B8509-3817-4E9B-98E4-440B0B018636Q37643652-242DF499-0C17-4C5A-9123-88E00B4244E8Q38892242-4D4C14F0-1714-436B-BD19-E0ACEE20EDB8Q39420787-35252C9A-BDB8-477B-9038-606A23D8781DQ39812716-2284D4D8-A933-40E8-9585-AF48F3656775Q40203926-A71D29BD-84B6-47B0-937D-706505434F6CQ41883627-5C20DE7E-5775-45B2-B241-D62BE68CA02BQ42663544-A0734E3F-C3EC-4CF8-A918-F9F482D5CE5BQ42710241-AB94EA24-A4B5-4F1E-90AD-1D67ABDE9D79Q48021428-ED65E5CC-7F52-4EEE-BF2C-9EB41BCC5826Q51042734-6ECCBA9E-B965-4E46-A062-BC84CE4E7464Q52837803-1B91B6F1-1FD5-4CBE-91C9-09553C2E0A94Q57817903-5CEDEFD4-6CA0-472A-9589-3CBD88962636
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Delivery of antimicrobials into parasites
@ast
Delivery of antimicrobials into parasites
@en
Delivery of antimicrobials into parasites
@en-gb
type
label
Delivery of antimicrobials into parasites
@ast
Delivery of antimicrobials into parasites
@en
Delivery of antimicrobials into parasites
@en-gb
prefLabel
Delivery of antimicrobials into parasites
@ast
Delivery of antimicrobials into parasites
@en
Delivery of antimicrobials into parasites
@en-gb
P2093
P2860
P50
P356
P1476
Delivery of antimicrobials into parasites
@en
P2093
B U Samuel
J Rothbard
M J Kirisits
P2860
P304
14281-14286
P356
10.1073/PNAS.2436169100
P407
P577
2003-11-17T00:00:00Z